文献速递咽喉与嗓音

沟通参与量表对单侧声带麻痹治疗前后患者报告结局的敏感性

Sensitivity of the Communicative Participation Item Bank for Measuring Patient-Reported Outcomes After Treatment of Unilateral Vocal Fold Immobility.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2021-01-01

该单组病例系列纳入25例单侧声带麻痹患者,比较治疗前后沟通参与量表(CPIB)评分变化。CPIB平均T分从治疗前40.95(95%CI 37.49-44.41)升至治疗后53.23(95%CI 48.41-58.04),平均差异-13.04(95%CI -7.30至-18.79),Cohen d为0.96。结果表明CPIB可用于评估此类患者治疗前后的沟通参与变化。

要点

  • CPIB治疗前后评分显著变化,效应量Cohen d为0.96。
  • CPIB Computerized adaptive testing仅需5-6个条目,短表需10个条目。
  • CPIB与VHI-10相关性治疗前中等(r=-0.70),治疗后强(r=-0.91)。

核心结论

  • CPIB对单侧声带麻痹患者治疗前后的沟通参与变化具有敏感性,可用于临床评估。

研究设计与样本

  • 单组病例系列,2014年3月至2019年3月从城市学术医疗中心便利抽样招募25例18岁以上单侧声带麻痹患者。

主要发现

  • CPIB平均T分治疗前40.95(95%CI 37.49-44.41),治疗后53.23(95%CI 48.41-58.04),平均差异-13.04(95%CI -7.30至-18.79),Cohen d为0.96。
  • CPIB短表与计算机自适应测试的Pearson相关系数治疗前r=0.93,治疗后r=0.95。
  • 计算机自适应测试通常需5至6个条目,短表需10个条目。
  • CPIB与VHI-10相关性治疗前r=-0.70(中等),治疗后r=-0.91(强)。
  • CPIB与临床医生评级嗓音质量相关性治疗前r=-0.52、治疗后r=-0.46;与自评嗓音质量相关性治疗前r=-0.56、治疗后r=-0.62。

临床怎么用

  • 可将CPIB用于单侧声带麻痹患者治疗前后的沟通参与评估,计算机自适应版本更高效。

局限性

  • 本研究为单组病例系列,样本量25例,治疗类型未控制,非随机对照设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The Communicative Participation Item Bank (CPIB) is a patient-reported outcome measure assessing the association between communication disorders and participation in daily communication. To our knowledge, no prior research has examined whether CPIB scores change after treatment of unilateral vocal fold immobility (UVFI). OBJECTIVE: To compare CPIB scores before and after treatment of UVFI and with patient-defined target treatment outcomes and other common clinical outcomes after UVFI intervention. DESIGN, SETTING, AND PARTICIPANTS: This single-group case series recruited a convenience sample of community-dwelling patients aged 18 years or older from an urban academic medical center who had a diagnosis of UVFI and planned to receive intervention for UVFI. The study was conducted from March 2014 to March 2019. EXPOSURES: Intervention for UVFI according to clinicians' recommendations. The treatment type was not controlled for this study. MAIN OUTCOMES AND MEASURES: Patients' self-reported communicative participation was assessed by obtaining CPIB scores before and after treatment of UVFI, with scores calibrated to the standardized T scale. Pearson correlations between the CPIB general short form and computerized adaptive format, the Voice Handicap Index-10 (VHI-10), and self-rated and clinician-rated voice severity were also evaluated. RESULTS: The sample included 25 participants, of whom 17 (68%) were male, 8 (32%) were female, and the mean (SD) age was 54.9 (17.0) years. Significant changes after treatment were observed in all quantitative outcomes including the primary outcome of the CPIB; the mean T score before treatment was 40.95 (95% CI, 37.49-44.41) and after treatment was 53.23 (95% CI, 48.41-58.04) (mean difference, -13.04 [95% CI, -7.30 to -18.79]; Cohen d, 0.96). The Pearson correlation between the CPIB general short form and computerized adaptive testing scores at pretreatment was r = 0.93 and at posttreatment, r = 0.95. Computerized adaptive testing showed efficiency advantages, with typically 5 to 6 items required for administration compared with 10 items for the short form. The correlation between the CPIB and VHI-10 was moderate before treatment (r = -0.70) and strong after treatment (r = -0.91). Moderate correlations were observed between the CPIB and clinician-rated voice quality before (r = -0.52) and after (r = -0.46) treatment and between CPIB and self-rated voice quality before (r = -0.56) and after (r = -0.62) treatment. CONCLUSIONS AND RELEVANCE: The results of this case series suggest that the CPIB is relevant for clinical use to assess changes in communicative participation among patients with UVFI before and after they receive treatment.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Baylor C, Merati AL, Eadie T, et al. Sensitivity of the Communicative Participation Item Bank for Measuring Patient-Reported Outcomes After Treatment of Unilateral Vocal Fold Immobility. JAMA Otolaryngol Head Neck Surg. 2021. PMID: 34529046. doi:10.1001/jamaoto.2021.2358

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。